6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

March, 2020

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨ No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number	Description of Exhibits
99.1	Intimation dated March 14, 2020

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: March 14, 2020	By:	/s/ Sandeep Poddar
		Name:	Sandeep Poddar
		Title:	Company Secretary

EX-99.1

Exhibit 99.1

Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507   Tel     :+91 40 4900 2900 Fax     :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

March 14, 2020
The General Manager,	The Manager,
Corporate Relations Department,	The Listing Department,
BSE Limited,	National Stock Exchange of India Limited,
P. J. Towers,	Exchange Plaza,
Dalal Street, Mumbai – 400001	C-1, Block G, Bandra Kurla Complex,
Scrip Code: 500124	Bandra East, Mumbai – 400051
	Symbol: DRREDDY - EQ

Dear Sir / Madam,

Subject:   Newspaper Advertisement with regard to Notice of Petition pursuant to the order of the Hon'ble National Company Law Tribunal, Hyderabad Bench at Hyderabad (‘Tribunal’)

We enclose herewith copies of the newspaper advertisements published in Business Standard (English daily) and Andhra Prabha (Telugu daily), Hyderabad edition on March 14, 2020 with regard to the hearing of the joint petition for sanction of Scheme of Amalgamation and Arrangement of Dr. Reddy’s Holdings Limited and Dr. Reddy’s Laboratories Limited and their respective shareholders pursuant to provisions of Sections 230-232 read with section 66 and other relevant provisions of the Companies Act, 2013 and rules framed thereunder.

The copy of the newspaper publications are also available on the website of the Company at https://www.drreddys.com/investors/investor-services/amalgamation.

This is for your information and record.

Thanking You,

Yours faithfully

For Dr. Reddy’s Laboratories Limited

/s/ Sandeep Poddar

Sandeep Poddar

Company Secretary

CC:- New York Stock Exchange Inc.(Stock Code :RDY)

Encl: as above

NCLT – Notice of Petition – Business Standard – March 14, 2020

NCLT – Notice of Petition – Andhra Prabha – March 14, 2020